ARTV Artiva Biotherapeutics, Inc. - Common Stock
$11,78
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$2–$15
78% of range
Analystenbewertung
BUY
12 analysts
Kursziel
$36
+204% upside
P/E (TTM)
-1.3
ROE
—
Nettogewinnmarge
—
ARTV Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$11.78
Marktkapitalisierung
—
P/E (TTM)
-1.3
EPS (TTM)
$-3.43
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$2 – $15
ARTV Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2023-12-31
→
2025-12-31
EPS
$-3.43
2023-12-31
→
2025-12-31
Freier Cashflow
—
2024-12-31
→
2024-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ARTV
Peer-Median
P/E (TTM)
-1.3
19.6
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ARTV
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ARTV
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ARTV
Peer-Median
Revenue YoY (Umsatz YoY)
-99.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ARTV
Peer-Median
ARTV Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
12 Analysten
- Starker Kauf 4 33,3%
- Kauf 7 58,3%
- Halten 1 8,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-18
Median
$40.00
Mittelwert
$35.80
← Unter allen Zielen
$11.78
Tief
$23.00
Hoch
$41.00
Median-Ziel
$40.00
+239,6%
Mittelwert-Ziel
$35.80
+203,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
Nächster Bericht
Aug 27, 2026
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.63 | $-0.64 | 0.01% |
| 31. März 2026 | $-0.95 | $-0.89 | -0.06% |
| 31. Dezember 2025 | $-0.85 | $-0.84 | -0.01% |
| 30. September 2025 | $-0.88 | $-0.89 | 0.01% |
| 30. Juni 2025 | $-0.87 | $-0.82 | -0.05% |
| 31. März 2025 | $-0.83 | $-0.72 | -0.11% |
| 31. Dezember 2024 | $-0.66 | $-0.77 | 0.11% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ARTV | — | -1.3 | -99.2% | — | — | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | |
| R&D Expense | $22M | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $27M | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | |
| Operating Income | $-27M | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | |
| Other Non-op | $-1.0K | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | |
| Net Income | $-25M | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| Shares (Basic) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| Shares (Diluted) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| EBITDA | $-27M | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | |
| Short-term Investments | $48M | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | |
| Receivables | · | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | |
| Prepaid Expense | $3M | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | |
| Current Assets | $352M | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | |
| Accum. Depreciation | $10M | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | |
| Other Non-current Assets | $809.0K | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | |
| Total Assets | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Accounts Payable | $1M | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | |
| Accrued Liabilities | $10M | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | |
| Current Liabilities | $15M | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | |
| Capital Leases | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | |
| Total Liabilities | $21M | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | |
| Retained Earnings | $-379M | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | |
| AOCI | $-21.0K | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | |
| Stockholders' Equity | $348M | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | |
| Liabilities + Equity | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Shares Outstanding | 48,792,279 | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $692.0K | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $307.0K | · | · | · | $-2M | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | |
| CapEx | $415.0K | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | |
| Investing Cash Flow | $18M | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | |
| Stock Issued | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $283M | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | |
| Net Change in Cash | $280M | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.3% | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | |
| ROE | -10.1% | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.2 | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | |
| Quick Ratio | 24.0 | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-87M | · | $-81M | $-77M | $-70M | · | $-38M | $-32M | · | · | |
| Market Cap | $473M | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | |
| P/E | -2.9 | -1.8 | · | -0.8 | -0.1 | -0.1 | · | -0.4 | · | · | · | |
| P/B | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Tangible Book | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Cash Flow | · | -7.6 | · | · | · | -3.7 | · | · | · | · | · | |
| P / FCF | · | -7.5 | · | · | · | -3.6 | · | · | · | · | · | |
| Earnings Yield | -34.3% | -54.8% | · | -122.0% | -1630.5% | -1366.3% | · | -249.4% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $0 | $251.0K | $33M |
| Betriebsgewinnmarge % | — | -26805.6% | — |
| Nettoergebnis | $-84M | $-65M | $-29M |
| Verwässerte EPS | $-3.43 | $-5.81 | $-35.78 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | — | 15.4 | — |
| Quick Ratio | — | 15.1 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | — | $-56M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 75 Einreicher · $384.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (+32 vs. Vorquartal) | 7 (+2 vs. Vorquartal) | 20 (+19 vs. Vorquartal) | 4 (-8 vs. Vorquartal) | +23.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174.169.727 | 17.955.642 | 45,32% | Aktien |
| VIKING GLOBAL INVESTORS LP | $25.260.410 | 2.604.166 | 6,57% | Aktien |
| Blackstone Inc. | $23.313.339 | 2.403.437 | 6,07% | Aktien |
| 5AM Venture Management, LLC | $22.827.049 | 2.353.304 | 5,94% | Aktien |
| Venrock Adviser, LLC | $19.822.881 | 2.043.596 | 5,16% | Aktien |
| FRANKLIN RESOURCES INC | $19.373.063 | 1.997.223 | 5,04% | Aktien |
| Caligan Partners LP | $16.840.277 | 1.736.111 | 4,38% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.523.606 | 981.815 | 2,48% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $9.262.152 | 954.861 | 2,41% | Aktien |
| Blue Owl Capital Holdings LP | $8.483.057 | 874.542 | 2,21% | Aktien |
| Propel Bio Management, LLC | $6.755.429 | 696.436 | 1,76% | Aktien |
| CITADEL ADVISORS LLC | $5.910.947 | 609.376 | 1,54% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5.092.500 | 525.000 | 1,33% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $3.049.438 | 314.375 | 0,79% | Aktien |
| Nantahala Capital Management, LLC | $2.910.000 | 300.000 | 0,76% | Aktien |
| Revelation Capital Management, LLC | $2.903.317 | 299.311 | 0,76% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $2.834.361 | 292.032 | 0,74% | Aktien |
| Alyeska Investment Group, L.P. | $2.654.066 | 273.615 | 0,69% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $2.526.035 | 260.416 | 0,66% | Aktien |
| KVP Capital Advisors, LP | $1.940.000 | 200.000 | 0,50% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.882.848 | 194.108 | 0,49% | Aktien |
| UBS Group AG | $1.757.019 | 181.136 | 0,46% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $1.697.500 | 175.000 | 0,44% | Aktien |
| STATE STREET CORP | $1.607.911 | 165.764 | 0,42% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.464.700 | 151.000 | 0,38% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.439.412 | 148.393 | 0,37% | Aktien |
| ADAR1 Capital Management, LLC | $1.150.653 | 118.624 | 0,30% | Aktien |
| Simplify Asset Management Inc. | $983.144 | 101.355 | 0,26% | Aktien |
| VANGUARD GROUP INC | $890.973 | 207.686 | 0,23% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $824.500 | 85.000 | 0,21% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $762.178 | 78.575 | 0,20% | Aktien |
| DAFNA Capital Management LLC | $650.880 | 67.101 | 0,17% | Aktien |
| Quadrature Capital Ltd | $478.647 | 49.345 | 0,12% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $434.686 | 44.813 | 0,11% | Aktien |
| XTX Topco Ltd | $412.337 | 42.509 | 0,11% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $301.796 | 31.113 | 0,08% | Aktien |
| Velan Capital Investment Management LP | $242.500 | 25.000 | 0,06% | Aktien |
| Atom Investors LP | $221.684 | 22.854 | 0,06% | Aktien |
| BAILARD, INC. | $200.790 | 20.700 | 0,05% | Aktien |
| Nuveen Asset Management, LLC | $187.599 | 18.611 | 0,05% | Aktien |
| Spark Investment Management LLC | $160.050 | 16.500 | 0,04% | Aktien |
| GOLDMAN SACHS GROUP INC | $153.066 | 15.780 | 0,04% | Aktien |
| Squarepoint Ops LLC | $144.094 | 14.855 | 0,04% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $135.606 | 13.980 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $116.187 | 11.978 | 0,03% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $115.391 | 11.896 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $59.170 | 6.100 | 0,02% | Aktien |
| Russell Investments Group, Ltd. | $53.263 | 5.491 | 0,01% | Aktien |
| State of Wyoming | $44.504 | 4.588 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $38.606 | 3.980 | 0,01% | Aktien |
| FMR LLC | $34.513 | 3.558 | 0,01% | Aktien |
| RHUMBLINE ADVISERS | $29.474 | 3.039 | 0,01% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $20.719 | 2.136 | 0,01% | Aktien |
| Federation des caisses Desjardins du Quebec | $19.400 | 2.000 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $18.422 | 1.923 | 0,00% | Aktien |
| CITIGROUP INC | $18.188 | 1.875 | 0,00% | Aktien |
| China Universal Asset Management Co., Ltd. | $15.520 | 1.600 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $11.136 | 1.148 | 0,00% | Aktien |
| NORTHERN TRUST CORP | $6.955 | 717 | 0,00% | Aktien |
| BlackRock, Inc. | $5.781 | 596 | 0,00% | Aktien |
| Legal & General Group Plc | $5.490 | 566 | 0,00% | Aktien |
| Steward Partners Investment Advisory, LLC | $4.850 | 500 | 0,00% | Aktien |
| BARCLAYS PLC | $4.792 | 494 | 0,00% | Aktien |
| Ameritas Investment Partners, Inc. | $4.084 | 421 | 0,00% | Aktien |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | $3.880 | 400 | 0,00% | Aktien |
| Tower Research Capital LLC (TRC) | $2.396 | 247 | 0,00% | Aktien |
| US BANCORP \DE\ | $2.280 | 235 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $2.000 | 224 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $1.940 | 200 | 0,00% | Aktien |
| Quarry LP | $912 | 94 | 0,00% | Aktien |
| Sterling Capital Management LLC | $698 | 72 | 0,00% | Aktien |
| MORGAN STANLEY | $398 | 41 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $221 | 22.940 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $126 | 13 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $106 | 11 | 0,00% | Aktien |
Unternehmensinsider 9 Insider · 8 Führungskräfte · 2 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | 19. Mai 2026 S | 1.535.082 | 0 | 3 | $-284.985 |
| Thad Allen Huston | Chief Financial Officer | 10. März 2026 A | 220.000 | 0 | 0 | $0 |
| Neha Krishnamohan | Chief Financial Officer | 15. November 2025 F | 99.356 | 0 | 0 | $0 |
| Gines Diego Miralles | President & Head of R&D | 18. Mai 2026 A | 77.500 | 0 | 0 | $0 |
| Jennifer Bush | COO, CLO, Compliance Officer | 19. Mai 2026 S | 337.920 | 0 | 1 | $-79.198 |
| Subhashis Banerjee | Chief Medical Officer | 19. Mai 2026 S | 144.963 | 0 | 1 | $-63.403 |
| Heather Raymon | SVP, Research and Development | 19. Mai 2026 S | 148.228 | 0 | 1 | $-27.886 |
| Christopher Horan | Chief Tech Operations Officer | 19. Mai 2026 S | 293.450 | 0 | 1 | $-63.088 |
| Elaine K. Sorg | Direktor | 18. Februar 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 Einreichungen | 23. Juli 2026 | 37,90% | Änderung | — | SEC |
| GC Corp, GC Cell Corporation, Yong-Jun Huh | 28. Mai 2026 | 12,30% | Änderung | — | SEC |
| GC Corp., GC Cell Corporation, Yong-Jun Huh | 29. Juli 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 11 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 15.784 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,00% | 35.800 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 137.793 SH | 8. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 3.029 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 269.149 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 699.899 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26.837 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.934 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.342 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,00% | 176 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 678 NS | 30. April 2026 | N-PORT |